CYCLERION THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CYCLERION THERAPEUTICS, INC. (CYCN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 351.04 thousand shares for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2023-11-13
- CYCLERION THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-09-30 was 351.04K shares.
- CYCLERION THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-09-30 was 7.80K shares.
- CYCLERION THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-06-30 was 7.70K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month |
|---|---|
| 2023-09-30 | 351.04K shares 10-Q · filed 2023-11-13 |
| 2019-09-30 | 7.80K shares 10-Q · filed 2019-11-12 |
| 2019-06-30 | 7.70K shares 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |